Solasia Pharma K.K Balance Sheet Health
Financial Health criteria checks 6/6
Solasia Pharma K.K has a total shareholder equity of ¥1.9B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥2.2B and ¥354.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | n/a |
Cash | JP¥728.00m |
Equity | JP¥1.88b |
Total liabilities | JP¥354.00m |
Total assets | JP¥2.23b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 9SO's short term assets (¥976.0M) exceed its short term liabilities (¥293.0M).
Long Term Liabilities: 9SO's short term assets (¥976.0M) exceed its long term liabilities (¥61.0M).
Debt to Equity History and Analysis
Debt Level: 9SO is debt free.
Reducing Debt: 9SO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 9SO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 9SO has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 3.9% each year.